Analyst Price Target is GBX 575
▼ -0.31% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Darktrace in the last 3 months. The average price target is GBX 575, with a high forecast of GBX 890 and a low forecast of GBX 260. The average price target represents a -0.31% upside from the last price of GBX 576.80.
Current Consensus is
Moderate Buy
The current consensus among 4 contributing investment analysts is to moderate buy stock in Darktrace. This rating has held steady since March 2024, when it changed from a Hold consensus rating.
Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Europe, and internationally. Its products include Darktrace PREVENT, an attack surface management that continuously monitors attack surface for risks, high-impact vulnerabilities, and external threats; and Darktrace DETECT, which analyzes thousands of metrics to reveal subtle deviations that may signal an evolving threat, including unknown techniques and novel malware, as well as installs in minutes, identifies threats, and avoids disruption. The company's products also include Darktrace RESPOND that works autonomously to disarm attacks whenever they occur and reacts to threats in seconds, as well as works 24/7 as it frees up security teams and resources; and Darktrace HEAL, which enables organizations to restore business affected by cyber-attacks to trusted operational states through AI assistance. The company was formerly known as Srenoog plc and changed its name to Darktrace plc in March 2021. Darktrace plc was founded in 2013 and is headquartered in Cambridge, the United Kingdom.
Read More